Viatris (VTRS) Total Non-Current Liabilities (2019 - 2026)

Viatris (VTRS) recorded quarterly Total Non-Current Liabilities of $20.1 billion in Q1 2026, down 1.82% quarter-over-quarter from $20.5 billion in Q4 2025, and down 4.22% on a YoY basis from $21.0 billion in Q1 2025.

Viatris (VTRS) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Viatris' Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $20.1 billion for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities fell 4.22% year-over-year to $20.1 billion; the TTM figure through Mar 2026 stood at $20.1 billion (down 4.22% YoY), while the FY2025 annual figure was $20.5 billion, down 2.19% from the prior year.
  • Total Non-Current Liabilities was $20.1 billion for Q1 2026 at Viatris, down from $20.5 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $31.1 billion in Q1 2022 to a low of $20.1 billion in Q1 2026.
  • Historically, Total Non-Current Liabilities has averaged $24.7 billion across 5 years, with a median of $25.7 billion in 2023.
  • The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities advanced 1.28% in 2024, then dropped 22.25% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $27.2 billion in 2022, then declined by 5.49% to $25.7 billion in 2023, then fell by 18.58% to $20.9 billion in 2024, then retreated by 2.19% to $20.5 billion in 2025, then retreated by 1.82% to $20.1 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $20.1 billion (Q1 2026), $20.5 billion (Q4 2025), and $20.9 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 Viatris - - 1.16 Bn 20.09 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 20.09 Bn
Dec 31, 2025 20.47 Bn
Sep 30, 2025 20.88 Bn
Jun 30, 2025 21.01 Bn
Mar 31, 2025 20.98 Bn
Dec 31, 2024 20.93 Bn
Sep 30, 2024 23.09 Bn
Jun 30, 2024 25.47 Bn
Mar 31, 2024 26.98 Bn
Dec 31, 2023 25.70 Bn
Sep 30, 2023 26.23 Bn
Jun 30, 2023 26.18 Bn
Mar 31, 2023 26.64 Bn
Dec 31, 2022 27.19 Bn
Sep 30, 2022 27.74 Bn
Jun 30, 2022 29.51 Bn
Mar 31, 2022 31.13 Bn
Sep 30, 2021 32.88 Bn
Jun 30, 2021 34.54 Bn
Mar 31, 2021 35.09 Bn